1
Return

Editor’s pick: Excelsior Sciences

delete2026-08-03
delete0
PRE
AI
C
Charlie Schmidt
DOI:10.1038/s41587-026-03249-3delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs.

Journal

Nature Biotechnology cover
Nature Biotechnology
IF:
41.7
Papers:
1.2W
Citations:
10.1W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers